Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

McNeil/Cilag (3 Nordic OTC drugs)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A portfolio of three Nordic over-the-counter drugs. The portfolio comprises of Treo, an acetylsalicylic acid composition that relieves pain, reduces fever and has an anti-inflammatory effect as well as two other drugs.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • Box 941
  • Norrbroplatsen 2
  • Helsingborg
  • Switzerland

McNeil/Cilag (3 Nordic OTC drugs) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore McNeil/Cilag (3 Nordic OTC drugs)‘s full profile, request access.

Request full access to PitchBook

McNeil/Cilag (3 Nordic OTC drugs) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore McNeil/Cilag (3 Nordic OTC drugs)‘s full profile, request access.

Request full access to PitchBook